End stage renal disease risk and neighbourhood deprivation: A nationwide cohort study in Sweden

• Chronic kidney disease has been associated with socioeconomic disparities and neighbourhood deprivation.
• The present study found that neighbourhood deprivation is independently associated with ESRD in both men and women.
• Both individual- and neighbourhood-level SES are important to consider in health care policies for patients with ESRD.

BackgroundChronic kidney disease has been associated with socioeconomic disparities and neighbourhood deprivation. We aimed to determine whether there is an association between neighbourhood deprivation and end stage renal disease (ESRD), and whether this association is independent of individual-level sociodemographic factors and comorbidities.MethodsNational Swedish data registers were used. The entire Swedish population aged 20–69 years was followed from January 1, 2001 until December 31, 2010. Data were analysed by multilevel logistic regression, with individual-level sociodemographic factors (age, marital status, family income, education level, country of birth, urban/rural status, and mobility) and comorbidities at the first level and neighbourhood deprivation at the second level.ResultsNeighbourhood deprivation was significantly associated with ESRD (age-adjusted odds ratio [OR] 1.45, 95% confidence interval [CI] 1.34–1.56 in men and OR 1.59, 95% CI 1.44–1.75 in women). The ORs for ESRD in men and women living in the most deprived neighbourhoods remained significantly increased when adjusted for age and individual-level sociodemographic factors (OR 1.25, 95% CI 1.15–1.35 in men and OR 1.30, 95% CI 1.17–1.44 in women). In the full model, which took account of sociodemographic factors and comorbidities, the ORs for ESRD remained significantly increased (OR 1.17, 95% CI 1.07–1.27 in men and OR 1.18, 95% CI 1.06–1.31 in women).ConclusionNeighbourhood deprivation is independently associated with ESRD in both men and women irrespective of individual-level sociodemographic factors and comorbidities.